Wong, T. Y. Et Al. 2024. Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.. Ophthalmology , vol.131, no.6 , 708-723.

Wong, T. Y., Haskova, Z., Asik, K., Baumal, C. R., Csaky, K. G., Eter, N., ... Ives, J. A.(2024). Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.. Ophthalmology , vol.131, no.6, 708-723.

Wong, Tien Et Al. "Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.," Ophthalmology , vol.131, no.6, 708-723, 2024

Wong, Tien Y. Et Al. "Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.." Ophthalmology , vol.131, no.6, pp.708-723, 2024

Wong, T. Y. Et Al. (2024) . "Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.." Ophthalmology , vol.131, no.6, pp.708-723.

@article{article, author={Tien Y Wong Et Al. }, title={Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.}, journal={Ophthalmology}, year=2024, pages={708-723} }